| Increasing risk of infectious complications after transrectal ultrasound–guided prostate biopsies: time to reassess antimicrobial prophylaxis? A Carignan, JF Roussy, V Lapointe, L Valiquette, R Sabbagh, J Pépin European urology 62 (3), 453-459, 2012 | 316 | 2012 |
| Risk of Clostridium difficile Infection after Perioperative Antibacterial Prophylaxis before and during an Outbreak of Infection due to a Hypervirulent Strain A Carignan, C Allard, J Pépin, B Cossette, V Nault, L Valiquette Clinical infectious diseases 46 (12), 1838-1843, 2008 | 212 | 2008 |
| Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British … DM Skowronski, Y Febriani, M Ouakki, S Setayeshgar, S El Adam, M Zou, ... Clinical Infectious Diseases 75 (11), 1980-1992, 2022 | 161* | 2022 |
| Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case–control study A Carignan, L Valiquette, C Grenier, JB Musonera, D Nkengurutse, ... Cmaj 192 (26), E702-E707, 2020 | 112 | 2020 |
| Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without … S Carazo, DM Skowronski, M Brisson, S Barkati, C Sauvageau, ... The Lancet Infectious Diseases 23 (1), 45-55, 2023 | 91 | 2023 |
| Efficacy of secondary prophylaxis with vancomycin for preventing recurrent Clostridium difficile infections A Carignan, S Poulin, P Martin, AC Labbé, L Valiquette, H Al-Bachari, ... Official journal of the American College of Gastroenterology| ACG 111 (12 …, 2016 | 91 | 2016 |
| Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers D Lane, I Matte, P Garde-Granger, C Laplante, A Carignan, C Rancourt, ... BMC cancer 15, 1-11, 2015 | 83 | 2015 |
| Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991–2005. C Allard, A Carignan, M Bergevin, I Boulais, V Tremblay, P Robichaud, ... Clinical Microbiology and Infection 14 (5), 421-428, 2008 | 76 | 2008 |
| Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in Quebec, Canada S Carazo, DM Skowronski, M Brisson, C Sauvageau, N Brousseau, ... JAMA network open 5 (10), e2236670-e2236670, 2022 | 73* | 2022 |
| CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling D Lane, I Matte, C Laplante, P Garde-Granger, A Carignan, P Bessette, ... Molecular Cancer 15, 1-11, 2016 | 68 | 2016 |
| 42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study GG Zhanel, HJ Adam, MR Baxter, J Fuller, KA Nichol, AJ Denisuik, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv5-iv21, 2019 | 54 | 2019 |
| Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a … S Poulin, C Corbeil, M Nguyen, A St-Denis, L Côté, F Le Deist, ... BMC Infectious Diseases 13, 1-6, 2013 | 44 | 2013 |
| 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial N Daneman, AH Rishu, R Pinto, P Aslanian, SM Bagshaw, A Carignan, ... Trials 19, 1-9, 2018 | 43 | 2018 |
| the risk of COVID-19 infection during neurosurgical procedures: a review of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) modes of transmission and … C Iorio-Morin, M Hodaie, C Sarica, N Dea, HJ Westwick, SD Christie, ... Neurosurgery 87 (2), E178-E185, 2020 | 42 | 2020 |
| Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories … AJ Denisuik, JA Karlowsky, HJ Adam, MR Baxter, PRS Lagacé-Wiens, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv64-iv71, 2019 | 36 | 2019 |
| Single-dose messenger RNA vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 in healthcare workers extending 16 weeks postvaccination: a test … S Carazo, D Talbot, N Boulianne, M Brisson, R Gilca, G Deceuninck, ... Clinical Infectious Diseases 75 (1), e805-e813, 2022 | 33* | 2022 |
| Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16 AR Golden, MR Baxter, RJ Davidson, I Martin, W Demczuk, MR Mulvey, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv39-iv47, 2019 | 32 | 2019 |
| Characterization of MRSA in Canada from 2007 to 2016 KA Nichol, HJ Adam, GR Golding, PRS Lagacé-Wiens, JA Karlowsky, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv55-iv63, 2019 | 32 | 2019 |
| Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study J Fuller, TC Dingle, A Bull, S Shokoples, M Laverdière, MR Baxter, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv48-iv54, 2019 | 30 | 2019 |
| Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study MG McCracken, HJ Adam, JM Blondeau, AJ Walkty, JA Karlowsky, ... Journal of Antimicrobial Chemotherapy 74 (Supplement_4), iv32-iv38, 2019 | 29 | 2019 |
Louis Valiquetteuniversité de SherbrookeAdresse e-mail validée de usherbrooke.ca
